Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma

While the advent of immunotherapy has revolutionized cancer treatment, its use in the treatment of glioblastoma (GBM) has been less successful. Most studies using immunotherapy in GBM have been negative and the reasons for this are still being studied. In clinical practice, interpreting response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, John Y., Ghannam, Jack Y., Choi, Bryan D., Gerstner, Elizabeth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959194/
https://www.ncbi.nlm.nih.gov/pubmed/36828374
http://dx.doi.org/10.3390/tomography9010022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959194/
https://www.ncbi.nlm.nih.gov/pubmed/36828374
http://dx.doi.org/10.3390/tomography9010022

Ejemplares similares